Elevai Labs Inc (ELAB)

$2.60 +0.04 (1.56%)
Market Cap 6.63M
Revenue (ttm) 1.71M
Net Income (ttm) -4.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -251.46%
Debt to Equity Ratio 0.06
Volume 378,291
Avg Vol 1,507,805
Day's Range N/A - N/A
Shares Out 2.59M
Stochastic %K 44%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The compan...

Industry: Biotechnology
Sector: Healthcare
Phone: 866-445-4886
Address:
120 Newport Center Drive, Suite 249, Newport Beach, United States
Fib7867
Fib7867 Aug. 7 at 4:30 AM
#myELABanalysis $ELAB #thurdayZ
0 · Reply
i8j0momma666
i8j0momma666 Aug. 6 at 9:39 PM
$ELAB .
0 · Reply
TokyoTrades
TokyoTrades Aug. 6 at 8:23 PM
Looks like volume and momentum are going to be shifting back in to CMCT now! Shorts overextended and now bulls can have them trapped at the bottom. CMCT Could make a huge multi day run - only 500k float for public! Don't miss CMCT ... it's breaking out now! $ELAB $DGLY $OP $NA xx
1 · Reply
i8j0momma666
i8j0momma666 Aug. 5 at 6:02 PM
$ELAB .
0 · Reply
PRODUCTOF90S
PRODUCTOF90S Aug. 5 at 3:58 PM
$ELAB Dont be another Tim!
0 · Reply
MACDgou
MACDgou Aug. 5 at 2:21 PM
$ELAB why does this one have so many burner accts?
0 · Reply
i8j0momma666
i8j0momma666 Aug. 4 at 10:31 PM
$ELAB .
0 · Reply
CumulativeChaser
CumulativeChaser Aug. 4 at 10:41 AM
$KUKE $IPDN $BLNE $ELAB :
0 · Reply
BitcoinBankers
BitcoinBankers Aug. 4 at 8:20 AM
Ticker GYRO is exploding in pre-market!! Could GYRO be todays big squeeze?! news just released.. 700k shares float.. watchers on GYRO are growing very fast. Would not be surprised if GYRO is todays big 300% runner. 20$+ break could send her parabolic! $SGD $SGBX $ELAB $DGLY /cm
1 · Reply
i8j0momma666
i8j0momma666 Aug. 4 at 7:23 AM
$ELAB .
0 · Reply
Latest News on ELAB
PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets

Jul 30, 2025, 7:45 AM EDT - 7 days ago

PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets

PMGC Holdings Inc. Completes Acquisition of CNC Machining Company - AGA Precision Systems LLC

Jul 18, 2025, 12:53 PM EDT - 19 days ago

PMGC Holdings Inc. Completes Acquisition of CNC Machining Company - AGA Precision Systems LLC

PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging with Over $2,000,000 in Combined Revenue for Fiscal Years 2023 and 2024

Jul 10, 2025, 8:30 AM EDT - 27 days ago

PMGC Holdings Inc. Completes Acquisition of Custom IT Packaging Company Pacific Sun Packaging with Over $2,000,000 in Combined Revenue for Fiscal Years 2023 and 2024

PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue

Jun 24, 2025, 8:30 AM EDT - 6 weeks ago

PMGC Holdings Inc. Signs Non-Binding LOI to Acquire CNC Aerospace Manufacturer Generating $4.5 Million in Annual Revenue

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

Jun 18, 2025, 9:52 AM EDT - 7 weeks ago

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases

Jun 17, 2025, 9:04 AM EDT - 7 weeks ago

Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years

Jun 16, 2025, 8:00 AM EDT - 7 weeks ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company

Jun 9, 2025, 8:00 AM EDT - 2 months ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company

NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia

May 22, 2025, 8:16 AM EDT - 2 months ago

NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia

PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q

May 14, 2025, 4:30 PM EDT - 3 months ago

PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

May 14, 2025, 8:00 AM EDT - 3 months ago

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)

TCRT

RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health

Apr 29, 2025, 12:15 PM EDT - 3 months ago

RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health

Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial

Apr 28, 2025, 8:00 AM EDT - 3 months ago

Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company

Apr 16, 2025, 8:00 AM EDT - 4 months ago

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company

Nestpoint Group Fuels Univest Securities, LLC's Ascent to Investment Banking Powerhouse in Trump's Economic Golden Age

Apr 7, 2025, 5:30 PM EDT - 4 months ago

Nestpoint Group Fuels Univest Securities, LLC's Ascent to Investment Banking Powerhouse in Trump's Economic Golden Age

BON

PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K

Mar 28, 2025, 8:00 AM EDT - 4 months ago

PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K

NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market

Mar 27, 2025, 8:00 AM EDT - 4 months ago

NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market

Univest Securities, LLC Announces Closing of $1.48 Million Registered Direct Offering for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

Mar 24, 2025, 5:00 PM EDT - 4 months ago

Univest Securities, LLC Announces Closing of $1.48 Million Registered Direct Offering for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules

Mar 21, 2025, 2:41 PM EDT - 4 months ago

PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules

PMGC Holdings Announces Share Repurchases from Existing Shareholders

Mar 21, 2025, 8:00 AM EDT - 4 months ago

PMGC Holdings Announces Share Repurchases from Existing Shareholders

PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group

Feb 27, 2025, 8:00 AM EST - 5 months ago

PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group

PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market

Feb 26, 2025, 8:30 AM EST - 5 months ago

PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1

Feb 4, 2025, 8:00 AM EST - 6 months ago

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

Jan 31, 2025, 10:33 AM EST - 6 months ago

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

Univest Securities, LLC Announces Closing of $1.92 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

Jan 28, 2025, 5:00 PM EST - 6 months ago

Univest Securities, LLC Announces Closing of $1.92 Million Warrant Inducement for its Client PMGC Holdings Inc. (NASDAQ: ELAB)

PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors

Jan 27, 2025, 9:00 AM EST - 6 months ago

PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium

Jan 24, 2025, 8:00 AM EST - 6 months ago

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium

PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture

Jan 16, 2025, 8:31 AM EST - 7 months ago

PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture

PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries

Jan 15, 2025, 9:30 AM EST - 7 months ago

PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy

Jan 2, 2025, 3:55 PM EST - 7 months ago

PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Dec 20, 2024, 7:30 PM EST - 8 months ago

Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Dec 20, 2024, 7:30 AM EST - 8 months ago

Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada

Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market

Dec 6, 2024, 7:30 AM EST - 8 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market

Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

Nov 22, 2024, 6:23 PM EST - 9 months ago

Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess

Nov 22, 2024, 5:00 PM EST - 9 months ago

Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess

CORRECTION - Elevai Labs Inc.

Nov 14, 2024, 2:35 PM EST - 9 months ago

CORRECTION - Elevai Labs Inc.

Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update

Nov 14, 2024, 9:08 AM EST - 9 months ago

Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange

Nov 4, 2024, 5:45 PM EST - 9 months ago

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

Oct 22, 2024, 9:54 AM EDT - 10 months ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

Oct 21, 2024, 7:30 AM EDT - 10 months ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock

Oct 4, 2024, 5:08 PM EDT - 10 months ago

Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock

REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Oct 3, 2024, 3:45 PM EDT - 10 months ago

REPEAT: Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Oct 3, 2024, 7:30 AM EDT - 10 months ago

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device

Oct 2, 2024, 8:30 AM EDT - 11 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device

Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB)

Sep 24, 2024, 5:00 PM EDT - 11 months ago

Univest Securities, LLC Announces Closing of $8.0 Million Registered Follow-on Offering for its Client Elevai Labs Inc. (NASDAQ: ELAB)

Dow Gains Over 50 Points; Elevai Labs Shares Plummet

Sep 23, 2024, 2:35 PM EDT - 11 months ago

Dow Gains Over 50 Points; Elevai Labs Shares Plummet

Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering

Sep 23, 2024, 8:45 AM EDT - 11 months ago

Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications

Sep 10, 2024, 7:30 AM EDT - 11 months ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology

Sep 3, 2024, 7:30 AM EDT - 1 year ago

Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology

Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™

Aug 28, 2024, 7:30 AM EDT - 1 year ago

Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™

Fib7867
Fib7867 Aug. 7 at 4:30 AM
#myELABanalysis $ELAB #thurdayZ
0 · Reply
i8j0momma666
i8j0momma666 Aug. 6 at 9:39 PM
$ELAB .
0 · Reply
TokyoTrades
TokyoTrades Aug. 6 at 8:23 PM
Looks like volume and momentum are going to be shifting back in to CMCT now! Shorts overextended and now bulls can have them trapped at the bottom. CMCT Could make a huge multi day run - only 500k float for public! Don't miss CMCT ... it's breaking out now! $ELAB $DGLY $OP $NA xx
1 · Reply
i8j0momma666
i8j0momma666 Aug. 5 at 6:02 PM
$ELAB .
0 · Reply
PRODUCTOF90S
PRODUCTOF90S Aug. 5 at 3:58 PM
$ELAB Dont be another Tim!
0 · Reply
MACDgou
MACDgou Aug. 5 at 2:21 PM
$ELAB why does this one have so many burner accts?
0 · Reply
i8j0momma666
i8j0momma666 Aug. 4 at 10:31 PM
$ELAB .
0 · Reply
CumulativeChaser
CumulativeChaser Aug. 4 at 10:41 AM
$KUKE $IPDN $BLNE $ELAB :
0 · Reply
BitcoinBankers
BitcoinBankers Aug. 4 at 8:20 AM
Ticker GYRO is exploding in pre-market!! Could GYRO be todays big squeeze?! news just released.. 700k shares float.. watchers on GYRO are growing very fast. Would not be surprised if GYRO is todays big 300% runner. 20$+ break could send her parabolic! $SGD $SGBX $ELAB $DGLY /cm
1 · Reply
i8j0momma666
i8j0momma666 Aug. 4 at 7:23 AM
$ELAB .
0 · Reply
i8j0momma666
i8j0momma666 Aug. 1 at 6:26 PM
$ELAB .
0 · Reply
HillBillyFarmer
HillBillyFarmer Aug. 1 at 3:30 PM
$ELAB On day like this, added some here.
0 · Reply
i8j0momma666
i8j0momma666 Aug. 1 at 4:43 AM
$ELAB .
0 · Reply
i8j0momma666
i8j0momma666 Jul. 31 at 8:32 PM
$ELAB .
0 · Reply
Cocacola1971
Cocacola1971 Jul. 30 at 8:37 PM
$ELAB Wait and wait and wait 😂😂😂😂
0 · Reply
Cocacola1971
Cocacola1971 Jul. 30 at 2:42 PM
$ELAB
0 · Reply
i8j0momma666
i8j0momma666 Jul. 30 at 2:40 PM
$ELAB .
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 30 at 11:49 AM
$ELAB PMGC Holdings Inc. Terminates LOI to Focus on Acquiring High-Growth CNC Precision Manufacturing Companies Serving Aerospace, Defense, and Industrial Markets By PMGC Holdings Inc. | July 30, 2025, 7:45 AM
0 · Reply
i8j0momma666
i8j0momma666 Jul. 30 at 2:03 AM
$ELAB .
0 · Reply
CaliforniaRunners
CaliforniaRunners Jul. 29 at 8:33 PM
Looks like volume and momentum are going to be shifting back in to MTEX! Shorts overextended and now bulls can have them trapped at the bottom. MTEX Could pull a huge multi day run - only 600k float! Don't miss MTEX ... $SGD $SGBX $ELAB $DGLY ms
0 · Reply
i8j0momma666
i8j0momma666 Jul. 29 at 5:48 AM
$ELAB .
0 · Reply
i8j0momma666
i8j0momma666 Jul. 28 at 4:22 PM
$ELAB .
0 · Reply